These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1346652)

  • 1. Centrally acting alpha 1-adrenoceptor agonists based on hexahydronaphth[2,3-b]-1,4-oxazines and octahydrobenzo[g]quinolines.
    Nozulak J; Vigouret JM; Jaton AL; Hofmann A; Dravid AR; Weber HP; Kalkman HO; Walkinshaw MD
    J Med Chem; 1992 Feb; 35(3):480-9. PubMed ID: 1346652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha-Adrenergic agents. 2. Synthesis and alpha 1-agonist activity of 2-aminotetralins.
    DeMarinis RM; Shah DH; Hall RF; Hieble JP; Pendleton RG
    J Med Chem; 1982 Feb; 25(2):136-41. PubMed ID: 6120238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is SDZ NVI-085 an alpha 1-adrenoceptor subtype-selective agonist?
    Büscher R; Insel PA; Michel MC
    Life Sci; 1994; 54(14):999-1007. PubMed ID: 7908116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha 2-adrenergic agonists/antagonists: the synthesis and structure-activity relationships of a series of indolin-2-yl and tetrahydroquinolin-2-yl imidazolines.
    Hlasta DJ; Luttinger D; Perrone MH; Silbernagel MJ; Ward SJ; Haubrich DR
    J Med Chem; 1987 Sep; 30(9):1555-62. PubMed ID: 2887657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of new linearly annulated tricycles as rigid dopamine congeners.
    Perrone R; Berardi F; Bettoni G; Tortorella V
    Farmaco Sci; 1988 Jan; 43(1):71-7. PubMed ID: 3396690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adrenoceptor agonist, SDZ NVI 085, discriminates between alpha 1A- and alpha 1B-adrenoceptor subtypes in vas deferens, kidney and aorta of the rat.
    Eltze M; Boer R
    Eur J Pharmacol; 1992 Dec; 224(2-3):125-36. PubMed ID: 1361446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolved monophenolic 2-aminotetralins and 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines: structural and stereochemical considerations for centrally acting pre- and postsynaptic dopamine-receptor agonists.
    Wikström H; Andersson B; Sanchez D; Lindberg P; Arvidsson LE; Johansson AM; Nilsson JL; Svensson K; Hjorth S; Carlsson A
    J Med Chem; 1985 Feb; 28(2):215-25. PubMed ID: 3968686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha 2-adrenoceptor agonists enhance responses to certain other vasoconstrictor agonists in the rat tail artery.
    Xiao XH; Rand MJ
    Br J Pharmacol; 1989 Mar; 96(3):539-46. PubMed ID: 2566348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypotensive and sedative effects of alpha-adrenoceptor agonists: relationship to alpha 1- and alpha 2-adrenoceptor potency.
    Clough DP; Hatton R
    Br J Pharmacol; 1981 Jul; 73(3):595-604. PubMed ID: 6113864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformationally defined adrenergic agents. 2. Catechol imidazoline derivatives: biological effects at alpha 1 and alpha 2 adrenergic receptors.
    DeBernardis JF; Kyncl JJ; Basha FZ; Arendsen DL; Martin YC; Winn M; Kerkman DJ
    J Med Chem; 1986 Apr; 29(4):463-7. PubMed ID: 2870187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of the alpha 2-adrenoceptor agonist rilmenidine.
    Van Zwieten PA
    Am J Cardiol; 1988 Feb; 61(7):6D-14D. PubMed ID: 2894160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of alpha-adrenoceptor agonists on cardiac output and its regional distribution in the pithed rat.
    Hiley CR; Thomas GR
    Br J Pharmacol; 1987 Jan; 90(1):61-70. PubMed ID: 2880628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic and regional hemodynamic characterization of alpha-1 and alpha-2 adrenoceptor agonists in pithed rats.
    Richer C; Lefevre-Borg F; Lechaire J; Gomeni C; Gomeni R; Giudicelli JF; Cavero I
    J Pharmacol Exp Ther; 1987 Mar; 240(3):944-53. PubMed ID: 2882016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of PN 200-110, a new calcium antagonist, on alpha 1- and alpha 2-adrenoceptor mediated vasoconstriction elicited by selective alpha-adrenoceptor agonists and catecholamines in the pithed rat.
    Jie K; van Brummelen P; Timmermans PB; Thoolen MJ; van Zwieten PA
    Arch Int Pharmacodyn Ther; 1985 Nov; 278(1):72-86. PubMed ID: 2869738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of alpha1-adrenoceptor subtypes in facilitation of rat spinal motoneuron activity.
    Wada T; Hasegawa Y; Ono H
    Eur J Pharmacol; 1997 Dec; 340(1):45-52. PubMed ID: 9527505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and structure-activity relationships of a new series of alpha-adrenergic agonists: spiro[(1,3-diazacyclopent-1-ene)-5,2'-(1',2',3',4'- tetrahydronaphthalene)].
    Cordi AA; Lacoste JM; Descombes JJ; Courchay C; Vanhoutte PM; Laubie M; Verbeuren TJ
    J Med Chem; 1995 Sep; 38(20):4056-69. PubMed ID: 7562941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha 2-adrenoceptor blocking profile of SK&F 104078: further evidence for receptor subtypes.
    Akers I; Coates J; Drew GM; Sullivan AT
    Br J Pharmacol; 1991 Apr; 102(4):943-9. PubMed ID: 1677300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of 2-[(5-methylbenz-1-ox-4-azin-6-yl)imino]imidazoline, a potent, peripherally acting alpha 2 adrenoceptor agonist.
    Munk SA; Harcourt D; Ambrus G; Denys L; Gluchowski C; Burke JA; Kharlamb AB; Manlapaz CA; Padillo EU; Runde E; Williams L; Wheeler LA; Garst ME
    J Med Chem; 1996 Aug; 39(18):3533-8. PubMed ID: 8784451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative relationships between alpha-adrenergic activity and binding affinity of alpha-adrenoceptor agonists and antagonists.
    Timmermans PB; de Jonge A; Thoolen MJ; Wilffert B; Batink H; van Zwieten PA
    J Med Chem; 1984 Apr; 27(4):495-503. PubMed ID: 6142954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p-Dimethoxy-substituted trans-octahydrobenzo[f]- and -[g]quinolines: synthesis and assessment of dopaminergic agonist effects.
    Cannon JG; Amoo VE; Long JP; Bhatnagar RK; Flynn JR
    J Med Chem; 1986 Dec; 29(12):2529-34. PubMed ID: 3783613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.